Related Experiment Videos
[Alzheimer's dementia and zinc]
1Université de Genève, Suisse.
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|January 1, 1990
Summary
Alzheimer's dementia involves amyloid production, leading to toxic metal accumulation and zinc deficiency. Restoring zinc levels may prevent neurodegeneration and cognitive decline.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Context:
- Alzheimer's dementia (AD) pathogenesis linked to amyloid (AM) production and subsequent Blood-Brain Barrier (BBB) disturbances.
- Toxic metal accumulation, particularly zinc displacement, observed in AD brain pathology.
- Amyloid production is genetically linked to chromosome 21.
Purpose:
- Investigate the role of zinc in Alzheimer's dementia pathogenesis.
- Explore the relationship between amyloid, metal toxicity, and neurofibrillary tangle formation.
- Propose zinc-based therapeutic strategies for Alzheimer's dementia.
Summary:
- Amyloid (AM) production in Alzheimer's dementia (AD) disrupts the Blood-Brain Barrier (BBB), allowing toxic metals to displace zinc.
- This zinc deficiency contributes to neurodegeneration, including Paired Helical Filaments (PHF) and Neurofibrillary Tangles (NFT) formation.
- Therapeutic interventions using zinc complexes that cross the BBB show promise in preventing metalotoxicity and restoring neuronal function.
Impact:
- Highlights the critical role of zinc homeostasis in Alzheimer's dementia.
- Suggests a novel therapeutic avenue targeting metal dysregulation and zinc deficiency.
- Provides a framework for understanding the interplay between amyloid, metals, and neurodegeneration.